Sf-900™ II SFM
FWS 제품은 특정 승인이 필요하므로 배송이 약 2-3주 더 소요됩니다.
Sf-900™ II SFM
Gibco™

Sf-900™ II SFM

Sf-900™ II SFM은 무혈청, 무단백질 곤충 세포 배양 배지로 Spodoptera frugiperda (Sf9, Sf21) 세포의 성장과 유지, BEVS (baculovirus expression vector자세히 알아보기
Have Questions?
보기 방식 변경buttonViewtableView
카탈로그 번호수량
10902096500 mL
109020881000 mL
109021046 x 1 L
카탈로그 번호 10902096
제품 가격(KRW)
94,000
キャンペーン価格
Ends: 31-Dec-2025
103,000
할인액 9,000 (9%)
Each
카트에 추가하기
수량:
500 mL
Customize this product
제품 가격(KRW)
94,000
キャンペーン価格
Ends: 31-Dec-2025
103,000
할인액 9,000 (9%)
Each
카트에 추가하기
Sf-900™ II SFM은 무혈청, 무단백질 곤충 세포 배양 배지로 Spodoptera frugiperda (Sf9, Sf21) 세포의 성장과 유지, BEVS (baculovirus expression vector system)로 발현되는 재조합 단백질 대량 생산에 최적화되어 있습니다. 이 배지는 suspension 및 monolayer 배양법에 적합하며 다른 lepidopteran cell line 성장도 돕습니다. Gibco™ Sf-900™ II SFM 특징:

• 우수한 장기간 고밀도 성장율
• 재조합 단백질 생성에 최적화
• 무혈청, 무단백질, ready-to-use 제형
• 높은 생물 배양기 확장성

우수한 장기간 고밀도 성장율
Sf-900™ II SFM에서 Spodoptera frugiperda (Sf9) 세포 성장률은 최대 세포 밀도 9 ∼ 12 x 106 cells ⁄ mL로 경쟁사 제형이나 Grace’s 배지보다 뛰어납니다(그림 1 참조). 최대 세포 밀도 20-100% 증가는 Lymantria dispar (Gypsy moth)와 Trichoplusia ni (Tn-368; Cabbage Looper) cell line에서도 관찰됩니다. Gibco™ Sf-900™ II SFM로는 >20 계대배양도 가능합니다.

재조합 단백질 생성에 최적화
원래 재조합 단백질 발현에는 10% FSB를 보충한 Grace 배지를 사용했습니다. Sf-900™ II SFM은 개선된 무혈청, 무단백질 배지로 Sf9와 기타 lepidopteran cell line 성장과 곤충 바이러스 및 rDNA 단백질 생성을 위해 만들어졌습니다.

무혈청, 무단백질, ready-to-use 제형
Gibco™ Sf-900™ II SFM는 무혈청, 무단백질 배지로 사용할 단백질 정제가 매우 간편합니다. Sf-900™ II SFM는 즉시 사용할 수 있도록 만들어져 있어 혈청, 글루타민, 계면활성제 첨가가 필요하지 않습니다. 다른 시판 무혈청 배지에 적용된 세포를 추가적인 적응 과정없이 바로 Sf-900™ II SFM에 넣어 배양을 진행할 수 있습니다. 혈청 함유 제형에서 가져오는 세포는 대개 일부 적응 과정이 필요합니다.

생물 반응기 확장성
대규모 세포 배양 시스템에서 Sf-900™ II SFM의 활용성은 5L Celligen™ bioreactor에서 입증되어 있습니다. 성공적인 rAcNPV 감염이 이루어져 rβ-Gal (그림 2)과 rEPO (그림 3)가 생성되었습니다.

용도
이 제품은 연구용으로만 사용해야 합니다. 치료 또는 진단 목적으로 동물이나 인간에 사용할 수 없습니다. 제조 공정에 Gibco™ Sf-900 II SFM을 사용하는 고객은 FDA 신청 시 당사에 Type II Drug Master File(DMF) 참조 인증서를 요청할 수 있습니다.

cGMP 제조 품질 시스템
Gibco™ Sf-900 II SFM은 New York Grand Island에 소재한 cGMP에 부합하는 시설에서 제조됩니다. 이 시설은 의료기기 제조자로 FDA에 등록되어 있으며 ISO 13485, ISO 9001 인증을 받은 기관입니다.

For Research Use or Further Manufacturing. Not for diagnostic use or direct administration into humans or animals.

사양
세포주Sf21, Sf9
세포 유형Insect Cell
제품라인Gibco, Sf-900
제품 유형Insect Cell Serum Free Medium (SFM)
수량500 mL
배송 조건Room Temperature
S. frugiperda, Spodoptera frugiperda
분류Protein-free, Serum-free
형태Liquid
Serum LevelSerum-free
첨가제 포함Glutamine
Unit SizeEach
구성 및 보관
Storage conditions: 2°C to 8°C. Protect from light
Shipping conditions: Ambient
Shelf life: 12 months from date of manufacture

자주 묻는 질문(FAQ)

How do I adapt my cells to serum-free medium?

Cells can be adapted by Sequential or Direct Adaptation. Suggested protocols for each are below, and you can also find more information by searching "Adaptation of Cell Cultures to a Serum-Free Medium" from our website home page.

SEQUENTIAL ADAPTATION
1) Subculture the cells growing in serum-supplemented medium into a 25%:75% mixture of SFM and serum supplemented medium.
2) When the cell density is 5 x 10E5 cells/ml, subculture the cells into a 50%:50% mixture of SFM and serum supplemented medium at a cell density 2.5 x 10E5 to 3 x 10E5 cells/ml.
3) Continue to subculture after the cell density 5 x 10E5 cells/ml in gradually increasing proportions of SFM until the serum is ~0.1% with about 85% cell viability.
4) Subculture the cells into SFM with an innoculum of 2.5 x 10E5 to 3 x 10E5 cells/ml.
5) When the cell density is 1 x 10E6 to 3 x 10E6 cells/ml (4 to 6 days post planting) subculture the cells again.
6) Stock cultures of SFM adapted cells should be subcultured in SFM every 3 to 5 days when the cell density is 1 x 10E6 to 3 x 10E6 cells/ml with 90% viability.

DIRECT ADAPTATION
Some cells can be directly adapted from serum-containing medium to SFM. For direct adaptation, the cell innoculum should be 1.5 x 10E5 to 3 x 10E5 cells/ml.
Cells should be subcultured when the cell density is 1 x 10E6 to 3 x 10E6 cells/ml. Cells are fully adapted to SFM when the cell density is 2 x 10E6 to 4 x 10E6 cells/ml after 4 to 7 days in culture.
Stock cultures of cells adapted to SFM should be subcultured in SFM every 3 to 5 days when the cell density is 1 x 10E6 to 3 x 10E6 cells/ml with 90% viability.

Why is it necessary to gradually adapt the cells to serum-free medium?

Some cells, such as insect cells, are sensitive to changes in their medium. By sequentially adapting cells, the medium is changed with minimal effects on cell growth.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

Can Sf9 cells in Sf-900 III SFM (Cat. No. 12659017) be thawed and grown in Sf-900 II SFM instead?

It should be okay to thaw the cells into Sf-900 II SFM. This is a richer media compared to the Sf-900 III SFM so the cells would have an easy time adapting. We would recommend taking the cells through 3 passages in the new medium before using them for any experiments as that they have enough time to adapt.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

What antimicrobials can be used in insect culture and at what concentration?

Many antibiotics are suitable for use with insect cells. The following antibiotics are commonly used:
- Penicillin/Streptomycine: 50-100 U/mL; 50-100 µg/mL
- Amphotericin B (Fungizone antimycotic): 0.25 µg/mL
- Gentamicin: 0.5 mL of 10 mg/mL solution in 500 mL media (final concentration: 10 µg/mL)

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

Is it necessary to heat-inactivate my serum before adding it to my medium?

Heat inactivation is not necessary. Our team has routinely used serum that has not been heat-inactivated, and we have not observed any effect on cell growth or morphology.

Many cells do not require heat-inactivated FBS. Some cells prefer heat-inactivated FBS. For instance, we use heat-inactivated FBS for our insect cell lines, i.e., Sf9 and Sf21 cells.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

인용 및 참조 문헌 (16)

인용 및 참조 문헌
Abstract
Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase.
Authors: Vickers Chad; Hales Paul; Kaushik Virendar; Dick Larry; Gavin James; Tang Jin; Godbout Kevin; Parsons Thomas; Baronas Elizabeth; Hsieh Frank; Acton Susan; Patane Michael; Nichols Andrew; Tummino Peter;
Journal:J Biol Chem
PubMed ID:11815627
'Human angiotensin-converting enzyme-related carboxypeptidase (ACE2) is a zinc metalloprotease whose closest homolog is angiotensin I-converting enzyme. To begin to elucidate the physiological role of ACE2, ACE2 was purified, and its catalytic activity was characterized. ACE2 proteolytic activity has a pH optimum of 6.5 and is enhanced by monovalent anions, which ... More
hsp90 is required for heme binding and activation of apo-neuronal nitric-oxide synthase: geldanamycin-mediated oxidant generation is unrelated to any action of hsp90.
Authors: Billecke Scott S; Bender Andrew T; Kanelakis Kimon C; Murphy Patrick J M; Lowe Ezra R; Kamada Yasuhiko; Pratt William B; Osawa Yoichi;
Journal:J Biol Chem
PubMed ID:11923316
'It is established that neuronal NO synthase (nNOS) is associated with the chaperone hsp90, although the functional role for this interaction has not been defined. We have discovered that inhibition of hsp90 by radicicol or geldanamycin nearly prevents the heme-mediated activation and assembly of heme-deficient apo-nNOS in insect cells. This ... More
The major conformational IgE-binding epitopes of hevein (Hev b6.02) are identified by a novel chimera-based allergen epitope mapping strategy.
Authors: Karisola Piia; Alenius Harri; Mikkola Jari; Kalkkinen Nisse; Helin Jari; Pentikäinen Olli T; Repo Susanna; Reunala Timo; Turjanmaa Kristiina; Johnson Mark S; Palosuo Timo; Kulomaa Markku S;
Journal:J Biol Chem
PubMed ID:11909866
'A novel approach to localize and reconstruct conformational IgE-binding epitope regions of hevein (Hev b6.02), a major natural rubber latex allergen, is described. An antimicrobial protein (AMP) from the amaranth Amaranthus caudatus was used as an immunologically non-IgE-binding adaptor molecule to which terminal or central parts of hevein were fused. ... More
Enhancing yield of infectious Bursal disease virus structural proteins in baculovirus expression systems: focus on media, protease inhibitors, and dissolved oxygen.
Authors: Hu Y C; Bentley W E;
Journal:Biotechnol Prog
PubMed ID:10585191
'Structural proteins of the poultry pathogen, infectious bursal disease virus (IBDV), were expressed in the baculovirus/insect cell expression system. To date, several reports have indicated that animal virus structural proteins are expressed only at low yield in this system. In this article, several factors were examined to enhance yield. These ... More
Crystal Structure of Imaginal Disc Growth Factor-2. A MEMBER OF A NEW FAMILY OF GROWTH-PROMOTING GLYCOPROTEINS FROM DROSOPHILA MELANOGASTER.
Authors: Varela Paloma F; Llera Andrea S; Mariuzza Roy A; Tormo Jose;
Journal:J Biol Chem
PubMed ID:11821393
'Imaginal disc growth factor-2 (IDGF-2) is a member of a recently described family of Drosophila melanogaster-soluble polypeptide growth factors that promote cell proliferation in imaginal discs. Although their precise mode of action has not been established, IDGFs cooperate with insulin in stimulating the growth of imaginal disc cells. We report ... More